Patent · US Active

Pyrrolopyrimidine comprising cyclopentyl substituent

US10617692B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignees

Inventors

Li Zhu · Shanghai, CN
Yangjian Liu · Beijing, CN
Chuanyu Zhang · Beijing, CN
He Wang · Shanghai, CN
Hong Luo · Clemson, US
Yinghui Sun · Beijing, CN
Yongxin Han · Kirkland, CA

Key dates

Filing date	Jun 15, 2017
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Jun 15, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pyrrolopyrimidine comprising a cyclopentyi substituent. The present invention specifically relates to a compound represented by formula. A and a stereoisomer and pharmaceutically acceptable salt thereof. The invention further relates to a method for manufacturing the pyrrolopyrimidine comprising the cyclopentyl substituent represented by formula A, a pharmaceutical composition, and an application of the compound in treating a disease induced by Janus kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.